AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Apple Restores Telegram to App Store After Content Policy Violation 
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
HORSHAM, Pa., March 29, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Monday, April 2, before the market opens. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 8:30 am Eastern Time to review the Company’s progress.
| Conference Call Details: | |
| Date: | Monday, April 2 |
| Time: | 8:30 am Eastern Time |
| Toll Free: | 888-394-8218 |
| International: | 323-794-2149 |
| Passcode: | 6380302 |
| Webcast: | www.strataskinsciences.com |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
| Investor Contacts: | |
| Frank McCaney, Chief Executive Officer | Bob Yedid, Managing Director |
| STRATA Skin Sciences, Inc. | LifeSci Advisors, LLC |
| 215-619-3200 | 646-597-6989 |
| [email protected] | [email protected] |
